Your Cart ( 1 Item )

• A Phase 2, Randomized, Controlled, Dose-Ranging Study Evaluating Crisaborole Topical Ointment, 0.5% and 2% in Adolescents With Mild to Moderate Atopic Dermatitis
  December 2015 | Volume 14 | Issue 12 | Original Article | 1394 | Copyright © December 2015
  Linda F. Stein Gold MD,^a Lynda Spelman MBBS FACD,^b Mary C. Spellman MD,^c Matilda H. Hughes CCRA,^d and Lee T. Zane MDd
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs